MedPath

Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus a Standard Eyechart.

Not Applicable
Completed
Conditions
Visual Acuity
Interventions
Device: EyeQue Insight
Registration Number
NCT04474041
Lead Sponsor
EyeQue Corp.
Brief Summary

Open label exploratory study of the EyeQue Insight in healthy volunteers \>=7 years of age.

Detailed Description

The primary objective of this study is to determine whether the EyeQue Insight (ETDRS visual acuity test) yields results similar to the standard ETDRS eyechart in the office.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria
  1. Male or Female
  2. Ages =>7 y.o.
  3. Subjects that are minors (<18 years old) must have a parent or legal guardian.
  4. Binocular vision
  5. Willing and able to give informed consent and follow all study procedures and requirements
  6. Fluent in English
Exclusion Criteria
  1. Has been diagnosed within 4 weeks, or currently has signs or symptoms, of COVID-19.

  2. Has traveled outside the country within the last 4 weeks

  3. Medications:

    a. Taking medications that may affect ability to follow instructions.

  4. Eye Disease:

    a. Subjects with eye disease deemed by the Investigator to be inappropriate for the study such as an active eye infection.

  5. Subjects that:

    1. Lack physical dexterity to properly operate the EyeQue App on the smartphone
    2. Lack the ability to follow instruction
    3. Lack binocular vision
    4. Lack the ability to maintain both eyes open

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Visual Acuity with a Hand-held Device Supported by Mobile App.EyeQue InsightThe Insight will be compared to a standard ETDRS eyechart
Primary Outcome Measures
NameTimeMethod
Acuity Visit 1Visit 1: Day 0

Variance of best-corrected (BCVA) monocular VA of each participant's OD and OS measured on the ETDRS chart and the ETDRS test of the EyeQue Insight at Visit 1.

Secondary Outcome Measures
NameTimeMethod
Acuity Visit 1 and 2Visit 1 (Day 0) and Visit 2 (Day 7)

Variance of the best-corrected VA (BCVA) of each participant's OD, OS, and OU measured on the ETDRS chart and the ETDRS test of the EyeQue Insight at Visit 1 and Visit 2.

Trial Locations

Locations (1)

EyeQue

🇺🇸

Newark, California, United States

© Copyright 2025. All Rights Reserved by MedPath